Treatment of relapsed CD20+ Hodgkin lymphoma with the monoclonal antibody rituximab is effective and well tolerated: results of a phase 2 trial of the German Hodgkin Lymphoma Study Group
| Autor: | Rehwald, Ute, Schulz, Holger, Reiser, Marcel, Sieber, Markus, Staak, Jan Oliver, Morschhauser, Franck, Driessen, Christoph, Rüdiger, Thomas, Müller-Hermelink, Konrad, Diehl, Volker, Engert, Andreas * |
|---|---|
| Zdroj: | In Blood 15 January 2003 101(2):420-424 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|